1 completed, 1 enrolling by invitation. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Enrolling by invitation 1 |
Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases Shingrix, vaccination with 2 doses of Shingrix vaccine - Systemic Vasculitis, Spondylarthropathies | Phase 4 | Enrolling by invitation | Region Skane | 240 | 2024-12-17 | 2025-01-10 |
| Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients dapagliflozin, placebo - SLE, Lupus Nephritis | Phase 4 | Completed | Mansoura University | 84 | 2022-10-01 | 2025-04-16 |
Arthritis (1) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Giant Cell Arteritis (1) · Herpes Zoster (1) · Lupus Nephritis (1) · Polymyalgia Rheumatica (1) · Scleroderma, Diffuse (1) · Spondylarthropathies (1) · Systemic Vasculitis (1)
Autoimmune Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Skin and Connective Tissue Diseases (2) · Arteritis (1) · Autoimmune Diseases of the Nervous System (1) · Bone Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · DNA Virus Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1)
Vaccination (1) · dapagliflozin (1)
Mansoura University (1) · Region Skane (1)
Egypt (1) · Sweden (1)
2023 (1)